Sitala Bio LTD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy (NCT07606352) | Sitala Bio LTD | 2026-08-04 |
| A Study in Adults With Geographic Atrophy (NCT07606365) | Sitala Bio LTD | 2026-06-01 |
Track Sitala Bio LTD automatically
Every clearance here is in the API, with alerts when new ones post.